Objectives Development of direct acting antivirals (DAA) offers new benefits for patients with chronic hepatitis C. The combination of these drugs with antiretroviral treatment (cART) is a real challe
Pharmacokinetic (PK) drug-drug interactions (DDIs) of oral haloperidol, a first-generation antipsychotic, are systematically reviewed. After exclusions, the search for DDIs with oral haloperidol prov
Note: Risk1 and risk2 are myopathy risks for drug 1 and drug 2 respectively. The risk-ratio is calculated as risk12/(risk1+risk2). The p-value is calculated from a multivariate logistic regression, in
Supplemental material, sj-xlsx-4-taj-10.1177_20406223221108391 for Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis by Jane Louisa
